SCHEMBL9873935

SCHEMBL9873935

COc1cccc2c3c(n(C)c12)SCC(Cn1ccnc1C)C3=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.48
CYP3A4 P08684 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
HTR3E A5X5Y0 1/20 0.48
SLC22A2 O15244 1/20 0.48
SLC22A1 O15245 1/20 0.48
SLC22A3 O75751 1/20 0.48
HTR3B O95264 1/20 0.48
CHRNB2 P17787 1/20 0.48
CHRNB4 P30926 1/20 0.48
CHRNA3 P32297 1/20 0.48
HTR2B P41595 1/20 0.48
CHRNA4 P43681 1/20 0.48
HTR3A P46098 1/20 0.48
HTR3D Q70Z44 1/20 0.48
SLC47A2 Q86VL8 1/20 0.48
HTR3C Q8WXA8 1/20 0.48
SLC47A1 Q96FL8 1/20 0.48
CYP19A1 P11511 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9870860 0.85 KCNH2 (0.48) KCNH2CYP3A4CYP1A2CYP2D6HTR3E
SCHEMBL9872217 0.84 KCNH2 (0.48) KCNH2CYP3A4CYP1A2CYP2D6HTR3E
SCHEMBL9372685 0.82 CYP3A4 (0.67) KCNH2CYP3A4CYP1A2CYP2D6HTR3E
SCHEMBL9871112 0.80 CYP3A4 (0.48) KCNH2CYP3A4CYP1A2CYP2D6HTR3E
SCHEMBL9871826 0.80 CYP3A4 (0.48) KCNH2CYP3A4CYP1A2CYP2D6HTR3E
SCHEMBL9872448 0.79 KCNH2 (0.50) KCNH2CYP3A4CYP1A2CYP2D6HTR3E
SCHEMBL9872735 0.78 CYP19A1 (0.41) CYP3A4CYP1A2CYP19A1NQO2KDM4E
SCHEMBL9870498 0.76 KCNH2 (0.50) KCNH2CYP3A4CYP1A2CYP2D6HTR3E
SCHEMBL9872914 0.75 CYP3A4 (0.44) KCNH2CYP3A4CYP1A2CYP2D6HTR3E
SCHEMBL9871585 0.74 KCNH2 (0.55) KCNH2CYP3A4CYP1A2CYP2D6HTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5030646-A Treatment of diseases resulting from disfunction of seretoninergic system ADIR ET COMPAGNIE (FR) 1991-07-09 US disclosed